Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Der Nervenarzt
|
September 24, 2002
[Botulinum toxin--the dose controls the poison. A historical sketch]
C N Homann, K Wenzel, N Kriechbaum, et al.
Clinical Immunology (Orlando, Fla.)
|
April 19, 2020
Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis
G Jordakieva, M Kundi, P Lemell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 1, 2003
Aerobic exercise for a patient suffering from metastatic bone disease
R Crevenna, M Schmidinger, M Keilani, et al.
Wiener Klinische Wochenschrift
|
October 28, 2004
[Botulinum toxin in Austria and neighboring countries]
C N Homann, N Kriechbaum, K Suppan, et al.
International Journal of Sports Medicine
|
March 22, 2001
Isokinetic strength testing in patients with chronic heart failure--a reliability study
M Quittan, G F Wiesinger, R Crevenna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2017
Effects of resistance exercise in prostate cancer patients: a meta-analysis
M Keilani, T Hasenoehrl, L Baumann, et al.
British Journal of Haematology
|
September 1, 1999
Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias
H W Auner, W Olipitz, G Hoefler, et al.
British Journal of Cancer
|
December 19, 2001
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
M Schmidinger, C Wenzel, G J Locker, et al.
British Journal of Haematology
|
May 8, 1999
Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia
H W Auner, M Klintschar, R Crevenna, et al.
European Journal of Cancer Care
|
July 19, 2008
Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy
M Grim-Stieger, M Keilani, R M Mader, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Der Nervenarzt
|
September 24, 2002
[Botulinum toxin--the dose controls the poison. A historical sketch]
C N Homann, K Wenzel, N Kriechbaum, et al.
Clinical Immunology (Orlando, Fla.)
|
April 19, 2020
Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis
G Jordakieva, M Kundi, P Lemell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 1, 2003
Aerobic exercise for a patient suffering from metastatic bone disease
R Crevenna, M Schmidinger, M Keilani, et al.
Wiener Klinische Wochenschrift
|
October 28, 2004
[Botulinum toxin in Austria and neighboring countries]
C N Homann, N Kriechbaum, K Suppan, et al.
International Journal of Sports Medicine
|
March 22, 2001
Isokinetic strength testing in patients with chronic heart failure--a reliability study
M Quittan, G F Wiesinger, R Crevenna, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 11, 2017
Effects of resistance exercise in prostate cancer patients: a meta-analysis
M Keilani, T Hasenoehrl, L Baumann, et al.
British Journal of Haematology
|
September 1, 1999
Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias
H W Auner, W Olipitz, G Hoefler, et al.
British Journal of Cancer
|
December 19, 2001
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
M Schmidinger, C Wenzel, G J Locker, et al.
British Journal of Haematology
|
May 8, 1999
Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia
H W Auner, M Klintschar, R Crevenna, et al.
European Journal of Cancer Care
|
July 19, 2008
Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy
M Grim-Stieger, M Keilani, R M Mader, et al.
Page
of 3